Main Session
Sep
28
SS 01 - CNS 1: Novel Approaches in Brain Metastases
105 - Use of Gadolinium Nanoparticles as Radiosensitizers for Brain Metastases: Results from the Phase 2 Multicentric Randomized Trial (NANORAD2)
Presenter(s)
Camille Verry, MD - CHU de Grenoble University Hospital, La Tronche, Rhone-Alpe